litlas
Log inCreate account

Mark J. Smyth

Active 1990–2022

359
Papers
111,096
Citations
172
h-index
359
i10-index

Citations

Citations per year for Mark J. Smyth1905: 2 citations1945: 1 citations1971: 2 citations1978: 1 citations1979: 2 citations1990: 2 citations1991: 11 citations1992: 12 citations1993: 14 citations1994: 18 citations1995: 28 citations1996: 40 citations1997: 35 citations1998: 33 citations1999: 73 citations2000: 125 citations2001: 210 citations2002: 388 citations2003: 443 citations2004: 591 citations2005: 630 citations2006: 605 citations2007: 706 citations2008: 751 citations2009: 719 citations2010: 812 citations2011: 867 citations2012: 982 citations2013: 1,164 citations2014: 1,114 citations2015: 1,629 citations2016: 1,757 citations2017: 1,985 citations2018: 1,890 citations2019: 4,817 citations2020: 5,768 citations2021: 5,611 citations2022: 4,406 citations2023: 3,340 citations2024: 4,064 citations2025: 1,945 citations2026: 42 citations1906–1944: no citations, so these years are not shown1946–1970: no citations, so these years are not shown1972–1977: no citations, so these years are not shown1980–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 11,443 citing papers, 25.4% of this breakdownChina: 7,713 citing papers, 17.1% of this breakdownGermany: 2,380 citing papers, 5.3% of this breakdownFrance: 2,033 citing papers, 4.5% of this breakdownUnited Kingdom: 2,026 citing papers, 4.5% of this breakdownItaly: 2,005 citing papers, 4.4% of this breakdownAustralia: 1,871 citing papers, 4.1% of this breakdownJapan: 1,523 citing papers, 3.4% of this breakdownCanada: 1,216 citing papers, 2.7% of this breakdownSpain: 955 citing papers, 2.1% of this breakdownNetherlands: 937 citing papers, 2.1% of this breakdownSwitzerland: 809 citing papers, 1.8% of this breakdown
0%25.4%Other 22.6%

Institutions

Fields

  • Medicine41.7%
  • Immunology and Microbiology31.9%
  • Biochemistry, Genetics and Molecular Biology20.8%
  • Engineering2.5%
  • Neuroscience0.8%
  • Materials Science0.5%
  • Other1.8%

Topics

  • Immune Cell Function and Interaction9.8%
  • Cancer Immunotherapy and Biomarkers9.1%
  • Immunotherapy and Immune Responses7.1%
  • CAR-T cell therapy research5.1%
  • T-cell and B-cell Immunology4.3%
  • Immune cells in cancer4%
  • Other60.6%

Coauthors

All papers

Open in search
  1. Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion

    Authors: Robert D. Schreiber, Lloyd J. Old, Mark J. Smyth - Science 2011 cited by 6,463

  2. Cancer immunoediting and resistance to T cell-based immunotherapy

    Authors: Jake S. O’Donnell, Michele W.L. Teng, Mark J. Smyth - Nature Reviews Clinical Oncology 2018 cited by 1,789

  3. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Authors: Lorenzo Galluzzi, Ilio Vitale, Sarah H. Warren, Sandy Adjemian, Patrizia Agostinis, Aitziber Buqué Martinez, Timothy A. Chan, George Coukos, Sandra Demaria, Éric Deutsch, Dobrin Draganov, Richard L. Edelson, Silvia C. Formenti, Jitka Fučíková, Lucia Gabriele, Udo S. Gaipl, Sofia R. Gameiro, Abhishek D. Garg, Encouse B. Golden, Jian Han, Kevin J. Harrington, Akseli Hemminki, James W. Hodge, Dewan Md Sakib Hossain, Tim Illidge, Michael Karin, Howard L. Kaufman, Oliver Kepp, Guido Kroemer, Juan José Lasarte, Sherene Loi, Michael T. Lotze, Gwenola Manic, Taha Merghoub, Alan Melcher, Karen Mossman, Felipe Prósper, Øystein Rekdal, María Rescigno, Chiara Riganti, Antonella Sistigu, Mark J. Smyth, Radek Špíšek, John Stagg, Bryan E. Strauss, Daolin Tang, Kazuki Tatsuno, Stefaan Van Gool, Peter Vandenabeele, Takahiro Yamazaki, Dmitriy Zamarin, Laurence Zitvogel, Alessandra Cesano, Francesco M. Marincola - Journal for ImmunoTherapy of Cancer 2020 cited by 1,061

  4. Type I interferons in anticancer immunity

    Authors: Laurence Zitvogel, Lorenzo Galluzzi, Oliver Kepp, Mark J. Smyth, Guido Kroemer - Nature reviews. Immunology 2015 cited by 1,301

  5. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors

    Authors: François Ghiringhelli, Lionel Apétoh, Antoine Tesnière, Laetitia Aymeric, Yuting Ma, Carla Ortiz, Karim Vermaelen, Theocharis Panaretakis, Grégoire Mignot, Evelyn Ullrich, Jean‐Luc Perfettini, F. Schlemmer, Ezgi Tasdemir, Martin Uhl, Pierre Génin, Ahmet Civas, Bernhard Ryffel, Jean Kanellopoulos, Jürg Tschopp, Fabrice André, Rosette Lidereau, Nicole M. McLaughlin, Nicole M. Haynes, Mark J. Smyth, Guido Kroemer, Laurence Zitvogel - Nature Medicine 2009 cited by 1,836

  6. The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies

    Authors: Tobias Bald, Matthew F. Krummel, Mark J. Smyth, Kevin C. Barry - Nature Immunology 2020 cited by 496

  7. Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease

    Authors: Jing Liu, Stephen J. Blake, Michelle C.R. Yong, Heidi Harjunpää, Shin Foong Ngiow, Kazuyoshi Takeda, Arabella Young, Jake S. O’Donnell, Stacey Allen, Mark J. Smyth, Michele W.L. Teng - Cancer Discovery 2016 cited by 864

  8. Targeting immunosuppressive adenosine in cancer

    Authors: Dipti Vijayan, Arabella Young, Michele W.L. Teng, Mark J. Smyth - Nature reviews. Cancer 2017 cited by 797

  9. Myeloid immunosuppression and immune checkpoints in the tumor microenvironment

    Authors: Kyohei Nakamura, Mark J. Smyth - Cellular and Molecular Immunology 2019 cited by 515

  10. Translational biology of osteosarcoma

    Authors: Maya Kansara, Michele W.L. Teng, Mark J. Smyth, David M. Thomas - Nature reviews. Cancer 2014 cited by 1,316

  11. Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

    Authors: Antonella Sistigu, Takahiro Yamazaki, Erika Vacchelli, Kariman Chaba, David Enot, Julien Adam, Ilio Vitale, Aïcha Goubar, Elisa Elena Baracco, Catarina Remédios, Laetitia Fend, Dalil Hannani, Laetitia Aymeric, Yuting Ma, Mireia Niso‐Santano, Oliver Kepp, Joachim L. Schultze, Thomas Tüting, Filippo Belardelli, Laura Bracci, Valentina La Sorsa, Giovanna Ziccheddu, Paola Sestili, Francesca Urbani, Mauro Delorenzi, Magali Lacroix‐Triki, Virginie Quidville, Rosa Conforti, Jean-Philippe Spano, Lajos Pusztai, Vichnou Poirier-Colame, Suzette Delaloge, Frédérique Penault‐Llorca, Sylvain Ladoire, Laurent Arnould, Joanna Cyrta, Marie-Charlotte Dessoliers, Alexander Eggermont, Marco E. Bianchi, Mikaël J. Pittet, Camilla Engblom, Christina Pfirschke, Xavier Préville, Gilles Uzé, Robert D. Schreiber, Melvyn T. Chow, Mark J. Smyth, Enrico Proietti, Fabrice André, Guido Kroemer, Laurence Zitvogel - Nature Medicine 2014 cited by 1,031

  12. Natural Innate and Adaptive Immunity to Cancer

    Authors: Matthew D. Vesely, Michael H. Kershaw, Robert D. Schreiber, Mark J. Smyth - Annual Review of Immunology 2011 cited by 2,043

  13. TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway

    Authors: Sébastien Viel, Antoine Marçais, Fernando Guimarães, Róisín M. Loftus, Jessica Rabilloud, Morgan Grau, Sophie Degouve, Sophia Djebali, Amélien Sanlaville, Emily Charrier, Jacques Bienvenu, Julien C. Marie, Christophe Caux, Jacqueline Marvel, Liam Town, Nicholas D. Huntington, Laurent Bartholin, David K. Finlay, Mark J. Smyth, Thierry Walzer - Science Signaling 2016 cited by 640

  14. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting

    Authors: Hirokazu Matsushita, Matthew D. Vesely, Daniel C. Koboldt, Charles G. Rickert, Ravindra Uppaluri, Vincent Magrini, Cora D. Arthur, J. Michael White, Yee-Shiuan Chen, Lauren Shea, Jasreet Hundal, Michael C. Wendl, Ryan Demeter, Todd Wylie, James P. Allison, Mark J. Smyth, Lloyd J. Old, Elaine R. Mardis, Robert D. Schreiber - Nature 2012 cited by 1,297

  15. IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases

    Authors: Michele W.L. Teng, Edward P. Bowman, Joshua McElwee, Mark J. Smyth, Jean‐Laurent Casanova, Andrea M. Cooper, Daniel J Cua - Nature Medicine 2015 cited by 857

  16. Classifying Cancers Based on T-cell Infiltration and PD-L1

    Authors: Michele W.L. Teng, Shin Foong Ngiow, Antoni Ribas, Mark J. Smyth - Cancer Research 2015 cited by 1,449

  17. Targeting natural killer cells in cancer immunotherapy

    Authors: Camille Guillerey, Nicholas D. Huntington, Mark J. Smyth - Nature Immunology 2016 cited by 1,081

  18. Control of Metastasis by NK Cells

    Authors: Alejandro López‐Soto, Segundo González, Mark J. Smyth, Lorenzo Galluzzi - Cancer Cell 2017 cited by 742

  19. New insights into cancer immunoediting and its three component phases — elimination, equilibrium and escape

    Authors: Deepak Mittal, Matthew M. Gubin, Robert D. Schreiber, Mark J. Smyth - Current Opinion in Immunology 2014 cited by 1,452

  20. Clinical relevance of host immunity in breast cancer: from TILs to the clinic

    Authors: Peter Savas, Roberto Salgado, Carsten Denkert, Christos Sotiriou, Phillip K. Darcy, Mark J. Smyth, Sherene Loi - Nature Reviews Clinical Oncology 2015 cited by 904

  21. Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells

    Authors: Yulong Gao, Fernando Souza-Fonseca-Guimarães, Tobias Bald, Susanna S. Ng, Arabella Young, Shin Foong Ngiow, Jai Rautela, Jasmin Straube, Nicola Waddell, Stephen J. Blake, Juming Yan, Laurent Bartholin, Jason S. Lee, Éric Vivier, Kazuyoshi Takeda, Meriem Messaoudene, Laurence Zitvogel, Michele W.L. Teng, Gabrielle T. Belz, Christian Engwerda, Nicholas D. Huntington, Kyohei Nakamura, Michael Hölzel, Mark J. Smyth - Nature Immunology 2017 cited by 640

  22. Targeting CD39 in cancer

    Authors: Achim K. Moesta, Xian-Yang Li, Mark J. Smyth - Nature reviews. Immunology 2020 cited by 328

  23. Combination cancer immunotherapies tailored to the tumour microenvironment

    Authors: Mark J. Smyth, Shin Foong Ngiow, Antoni Ribas, Michele W.L. Teng - Nature Reviews Clinical Oncology 2015 cited by 976

  24. Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

    Authors: Sherene Loi, Stefan Michiels, Roberto Salgado, Nicolas Sirtaine, Vinu José, Debora Fumagalli, Pirkko Kellokumpu‐Lehtinen, Petri Bono, Vesa Kataja, Christine Desmedt, Martine Piccart, Sibylle Loibl, Carsten Denkert, Mark J. Smyth, Heikki Joensuu, Christos Sotiriou - Annals of Oncology 2014 cited by 1,270